Cannabis News
Market-moving headlines, earnings, and regulatory shifts across the cannabis sector
Track the developments that move cannabis stocks — from quarterly earnings and M&A deals to state-level legalization votes and federal policy changes. Articles are tagged with relevant stock tickers so you can see which companies are affected and jump straight to their market data.
First Nation Cannabis Protest Shuts Down BC Highway Over Enforcement
Indigenous cannabis operators block major British Columbia highway in protest of government crackdown, highlighting ongoing jurisdictional tensions in Canadian market.
Medicare Advantage Opens Door to Hemp Products Under New Federal Rule
Federal regulators finalize policy allowing hemp-derived products as covered benefits, creating new revenue streams for cannabis companies targeting seniors market.
Weed Inc (BUDZ) Surges 9.8% Despite Limited Trading Volume
Micro-cap MSO Weed Inc rallied nearly 10% to $0.03 on modest volume, highlighting volatility in penny cannabis stocks.
Delivra Health Brands Surges 10.5% on Volume Spike
DHBUF climbed to $0.14 amid increased trading activity, though the CBD company remains well below its 52-week high of $0.26.
Virginia Preps Cannabis Authority Hiring Spree Ahead of Sales Launch
Virginia Cannabis Control Authority posts 11 new positions as Governor Spanberger weighs adult-use sales legislation, signaling state readiness for market launch.
Lifeist Wellness Surges 24.5% on Low Volume Despite Market Cap Concerns
LFSWF climbed to $0.03 with modest trading volume of 10,645 shares, highlighting volatility in micro-cap cannabis stocks.
Greater Cannabis Company Crashes 36% as Stock Nears Annual Lows
GCAN plummeted to $0.12 amid heightened volatility, trading just above its 52-week low of $0.05 with limited trading volume of 27,000 shares.
FinCanna Capital Surges 38% Despite Trading at Zero Valuation
FNNZF jumps 38.1% on 10,200 shares traded, highlighting extreme volatility in micro-cap cannabis ancillary space.
Pineapple Express Cannabis Surges 111% Despite Zero Valuation
PNXP experienced massive trading volume of 907k shares amid technical pricing anomalies in the OTC cannabis market.
NC Cannabis Commission Backs Adult-Use Legalization Framework
Governor-appointed panel recommends replacing criminal penalties with regulated THC market for adults in latest state expansion push.
TPCO Holding Plunges 13% as Cannabis Stock Volatility Continues
TPCO Holding (GRAMF) dropped 13% to $0.16 amid heightened trading volume, reflecting ongoing challenges in the cannabis sector.
Maryland Advances Cannabis Employment Rights for First Responders
State lawmakers push workplace protections for firefighters using medical cannabis off-duty, signaling broader shift in employment law across legal markets.
FBI Clears Agents for Hemp Investments, Maintains Cannabis Ban
Declassified FBI memo allows agents to invest in hemp companies while maintaining prohibition on marijuana industry participation, highlighting federal regulatory divide.
FBI Memo Creates Investment Split Between Hemp and Cannabis Sectors
Declassified FBI guidance allows agents to invest in hemp companies while prohibiting marijuana investments, highlighting regulatory divide affecting sector valuations.
PharmaCielo Plunges 26% as Cannabis Stock Hits New Lows
PharmaCielo shares tumbled 26.4% to $0.04, marking another painful decline for the struggling CBD company trading near penny stock levels.
NY Cannabis Chief Signals Hemp Policy Shift, Market Expansion Ahead
New York's cannabis regulator outlines hemp framework changes and market expansion plans that could reshape industry dynamics and unlock new revenue streams.
Trees Corp (CANN) Jumps 14.3% on Heavy Volume Trading
Multi-state operator Trees Corp sees significant price movement amid increased investor activity, though trading remains at penny stock levels.
Blueberries Medical Surges 19% on Penny Stock Rally
BBRRF jumps to $0.01 with elevated volume as investors eye the international cannabis operator's potential turnaround prospects.
Attorney General Pick Creates Cannabis Rescheduling Uncertainty
New DOJ leadership could reshape federal cannabis policy timeline as industry awaits Schedule III implementation
Healthcare Cannabis Stocks Trade Below Growth Fundamentals
Market share expansion in medical cannabis outpaces investor recognition, creating valuation gaps across healthcare-focused operators.